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Abstract
Purpose of Review This review aims to survey recent trends in electrical forms of neuromodulation, with a specific application to
Parkinson’s disease (PD). Emerging trends are identified, highlighting synergies in state-of-the-art neuromodulation strategies,
with directions for future improvements in stimulation efficacy suggested.
Recent Findings Deep brain stimulation remains the most common and effective form of electrical stimulation for the treatment
of PD. Evidence suggests that transcranial direct current stimulation (tDCS) most likely impacts the motor symptoms of the
disease, with the most prominent results relating to rehabilitation. However, utility is limited due to its weak effects and high
variability, with medication state a key confound for efficacy level. Recent innovations in transcranial alternating current
stimulation (tACS) offer new areas for investigation.
Summary Our understanding of the mechanistic foundations of electrical current stimulation is advancing and as it does so,
trends emerge which steer future clinical trials towards greater efficacy.
Keywords Parkinson’s disease (PD) . Deep brain stimulation (DBS) . Non-invasive transcranial brain stimulation (NTBS) .
Transcranial direct current stimulation (tDCS) . Transcranial alternating current stimulation (tACS) . Direct cortical stimulation
Introduction
Aswe pass the bicentennial of James Parkinson’s seminal essay
on the shaking palsy [1], it is fitting to acknowledge that great
strides have been made in our understanding and management
of this common neurological condition (2). While many ap-
proaches to neuromodulation have been trialled in the treatment
of Parkinson’s disease (PD) over the years, the most striking is
undoubtedly the advent of levodopa as a front-line treatment.
The effectiveness of this pharmacological manipulation is re-
markable, yet leads to gross motor complications including
devastating levodopa-induced dyskinesias (for a review, see
[3]). In 1990, it was observed that lesioning the subthalamic
nucleus (STN) reversed experimental Parkinsonism [4]. This
seminal observation was followed by the first trial of deep brain
stimulation (DBS) of the STN in 1994 as a treatment for PD [5].
The procedure proved remarkably effective at ablating both the
hyper- and hypo-kinetic symptoms of the condition. DBS has
since become a common treatment for a range of disorders,
with over 100,000 people having undergone implantation
worldwide [6]. More recently, transcranial current stimulation
(tCS) has re-emerged as a method to non-invasively modulate
brain activity and has been trialled in a variety of guises to treat
a number of neurological disorders, including PD.
This review will focus on recent trends in the therapeutic
application of electrical forms of neuromodulation, with a
specific focus on PD. We briefly survey the use of DBS,
transcranial direct current stimulation (tDCS) and transcranial
alternating current stimulation (tACS) with application to PD,
drawing parallels and highlighting differences between these
approaches where appropriate. Direct (invasive) cortical stim-
ulation is considered, with perspectives for future applica-
tions. Electroconvulsive therapy (ECT) is not directly
discussed, but recent reviews and perspectives are available
[7, 8]. Common goals and cross-modal perspectives are given,
regarding emerging neuromodulation strategies. The focus on
electrical forms of neuromodulation will necessarily omit a
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wealth of recent technological developments and innovations
which remain outside the scope of this review; notably MR-
guided ultrasound [9, 10] which has garnered much recent
attention for achieving focussed unilateral sub-cortical lesions.
For an overview of PD pathology, management and treatment,
the reader is directed towards the excellent bicentennial essay
of Obeso et al. [2].
While the various forms of stimulation considered here
involve the application of electrical currents, the approaches
and mechanism of action of DBS, tDCS and tACS are quite
distinct and will necessitate tailored strategies in therapeutic or
rehabilitative applications. DBS is an invasive neurosurgical
procedure where electrical impulses are delivered to precise,
stereotactically targeted regions of the brain. tDCS meanwhile
involves the application of broad non-invasive transcranial
electric fields that modulate cortical excitability in a stimula-
tion polarity dependent fashion [11]. tACS operates principal-
ly through sub-threshold electrical modulation of the mem-
brane potential and is hypothesised to induce synchronous
states [12]. Yet despite these seemingly disparate approaches,
with distinct mechanistic underpinnings, all have been trialled
to treat PD and share common traits. One striking similarity is
the push towards patient-centric, tailored forms of therapy that
include complex field steering and the advent of on-demand
and closed-loop strategies. Here, we review recent advances in
their respective fields, drawing parallels where appropriate to
guide future efforts with the ultimate goal of focussing inves-
tigations towards greater clinical utility.
Deep Brain Stimulation
DBS has proven remarkably effective at alleviating both the
hypo- and hyper-kinetic symptoms of PD [13, 14], achieving
its therapeutic benefit through the delivery of brief high-
frequency (typically in excess of 100 Hz) electrical impulses
to targeted nuclei through electrodes implanted in sub-cortical
regions of the brain that would otherwise remain inaccessible
to intervention. Indeed, DBS remains the most prevalent neu-
rosurgical procedure for PD [15], providing effective relief of
motor and some non-motor symptoms [16]. However, as pre-
viously noted [17], DBS hardware has remained largely static
for many years, likely a victim of its own success. Yet a raft of
recent innovations stand ready to allow tailored forms of stim-
ulation that may alleviate unwanted side-effects, or even boost
the efficacy of stimulation itself. While the exact mechanism
of action of DBS still remains unknown, it is now believed
that DBS efficacy is rooted in a reversible information lesion
that disrupts the expression of pathological neural activity
across the motor circuit [18]. In the case of PD, the classic
electrophysiological hallmark in the basal ganglia is elevated
beta (13–30 Hz) activity [19], which is suppressed by dopa-
mine and high-frequency DBS [20–24].
Field Shaping
Although DBS delivers a focal form of stimulation with elec-
trodes entrenched directly in neural tissue, the distribution of
the induced electric field is ultimately reliant upon the geom-
etry of the electrode contacts. Traditionally these have been
cylindrical, producing an omnidirectional field. However, it
has long been known that stimulation of adjacent structures
can lead to unwanted side-effects including, most commonly,
parasthesias and dysarthria [25]. Recently, the first reports on
the clinical efficacy of electric field shaping were published, a
technique achieved through the implantation of next-
generation electrodes that possess either segmented electrodes
(typically breaking each cylindrical contact into three radial
aspects), or more generic multi-contact designs, permitting the
formation of complex stimulation fields.
The first double-blind study into the efficacy of directional
DBS electrodes found that the preferred orientation for stim-
ulation significantly improved the therapeutic window over
alternate directions, and over omnidirectional stimulation
[26]—a result which has since been confirmed [27–32]. The
therapeutic window not only takes into account the suppres-
sion of motor symptoms but also considers the onset of
stimulation-induced side effects. However, the added com-
plexity of programming segmented electrodes emphasises
the need for electrophysiological biomarkers to guide contact
selection, and perhaps even tune stimulation parameters.
Spectral analysis of local field potentials (LFPs) from direc-
tional electrodes have already identified localised spectral sig-
natures of beta (and tremor) activity [30, 31, 33] and have
directly related stimulation at those contacts to broader thera-
peutic windows [30, 31].
Adaptive Stimulation
DBS therefore provides a highly focal, if functionally non-
specific form of neuromodulation. Essentially, stimulation is
not reactive to the current brain state [34]; although this does
not imply that the effects of stimulation are not brain-state
dependent, as elevated levels of beta and tremor-related sig-
nals appear more strongly modulated than similar activity oc-
curring at lower intensities, or activity residing in other fre-
quency bands [35]. Despite this, while high-frequency pulse
trains are effective in improving the motor (and some non-
motor) aspects of the disease, DBS can produce unwanted
behaviours such as impulsivity [36], parasthesias, dysarthria,
postural instabilities, and even weight gain [37]. It has been
proposed that on-demand stimulation can assist here, where
DBS is delivered only when pathophysiological neural activ-
ity (linked to disease symptoms) are detected [38]. So far, such
trials are limited, but there is evidence to suggest that on-
demand stimulation, delivered only when elevated neural ac-
tivity in the beta-frequency band is present, can improve PD
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motor scores beyond that of continuous high-frequency DBS,
while avoiding unwanted side-effects such as speech distur-
bances [38]. Alternatively, fully closed-loop strategies can be
employed that interact with specific neural activity [39••].
Akin to its high-frequency counterpart, low-frequency
stimulation (below 100 Hz) can provide therapeutic benefits
(in gait, for instance [40]), can be associated with motor deg-
radation [41], and (at very low frequencies) has even been
shown to aid cognitive performance in PD [42]. These multi-
farious findings reassert the dependency between stimulation
parameters (such as frequency and intensity) and behavioural
outcomes, and further highlight the need for intelligent forms
of on-demand closed-loop stimulation that can selectively
abate motor symptoms without disrupting (or perhaps even
actively normalising) cognitive processes.
Unlike transcranial forms of stimulation, the electrodes
employed in DBS directly innervate neural tissue, leading to
a form of neuro-stimulation that is strong enough (in most
cases at least) to supplant endogenous neural activity. This
gives rise to the notion of an information lesion [18].
However, when the frequency (and hence the electrical ener-
gy) of stimulation is reduced, signs of brain-state dependence
becomemore noticeable [41]. For instance, the timing of DBS
pulses can be adjusted to coincide with the timing of rhythmic
tremor production [43]. In Essential Tremor (ET), this leads to
both entrainment and phase-specific modulation of tremor se-
verity [44], while in PD the effects appear limited to tremor
entrainment, with no significant modulation of tremor severity
[43]. Indeed, similar results have been observed when regular
pauses are introduced into the stimulation pulse-train, which
leads to entrainment [45]. Such stimulation demonstrates that
PD tremor is tolerant of intrinsic departures from its median
frequency, unlike ET [39••, 46, 47]. Takenwith other evidence
(e.g. [48–50]), this gives rise to the question of whether PD
tremor may in-fact represent a source of filtered noise. These
characteristics are important for determining the most effec-
tive form of stimulation. While in ET, one could consider
targeting specific phases of the tremor cycle [39••], in PD a
strategy that overcomes the relative tolerance of the tremor
generating system, or targets an alternative stimulation site
(such as the motor cortex [51]), may be preferable.
Transcranial Direct Current Stimulation
The field of tDCS has expanded rapidly over the past 20 years
[52, 53]. With this, our understanding of the impact and inter-
action of tDCS with the brain, especially its pharmacological
dependencies, have also developed. Novel electrode configu-
rations have been introduced which promise to deliver stimu-
lation in a more focal manner than ever before.
Despite these advances, recent evidence-based guide-
lines [54] reveal a chronic lack of sham-controlled randomised
controlled tDCS trials in PD, leading to an inability of the
authors to provide firm recommendations due to the small num-
ber of eligible studies. A lack of replication in protocols and
experimental factors, such as the location of stimulating elec-
trodes, further confound the problem. Nevertheless, it was con-
cluded that there was a potential impact of anodal tDCS
targeting the motor cortex on gait and motor symptoms from
the small number of eligible studies [54]. These supported the
notion that combining tDCS with rehabilitative strategies to
enhance recovery/motor learning provided the greatest thera-
peutic promise [54, 55]. A further intriguing development
was the finding that anodal TDCS could enhance survival
and integration of dopaminergic cells in a rat model of
Parkinson’s disease [56]. Thus, as in the case of rehabilitation,
tDCS may make its major contribution in facilitating primary
interventions, in this case cell transplantation therapies.
Pharmacological Action and Interaction
It has long been recognised that tDCS effects are suscepti-
ble to pharmacological state [57]. Indeed, a recent review
on the sensitivity of tDCS to medication state emphasised
that a wide variety of drugs can reduce, enhance, or even
reverse excitability effects [58•]. As such, a more thorough
understanding of the underlying brain state, as influenced
by medication and stimulation, is needed. This can be
aided by proper documentation of medication states during
experiments. Of course, physiological variability may also
help to explain the broad array of sometimes contradictory
evidence present in the tDCS literature (see [59]). Perhaps
most importantly in relation to PD is the effect of dopa-
mine, which produced both a dose-dependent, and receptor
specific impact on tDCS excitability [60–62], with one
study reporting an inverted-U shaped dose-dependent re-
sponse [61]. Of course, tDCS itself results in neurochemi-
cal changes, with anodal tDCS most strongly associated
with modulation of GABAergic, and also glutamatergic
concentrations [57, 63, 64]. It is likely that these circular
dependencies may be responsible for some paradoxical
long-term responses to stimulation, including the time-
dependent reversal of effects. A proper consideration of
medication state is therefore a critical element when con-
sidering tDCS in trials of PD. Moreover, anatomical dif-
ferences could influence and confound the stimulation ef-
fects both at the site of stimulation and on downstream
nuclei. Specifically, it has been shown that axonal orienta-
tion could influence whether direct current stimulation re-
sults in excitation or inhibition [65]. However, how axonal
orientation influences the net stimulation effect in compli-
cated brain structures such as the motor cortex is still de-
bated [66, 67].
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Field Shaping
A further consideration is the shape of the electric field gen-
erated by tCS, which dictates the area of electrical innervation
in the brain. This is dependent upon the number, and geomet-
ric arrangement of stimulating electrodes, and must also take
into account the complex conductivity of the brain itself. The
electrodes can be positioned in a centre-surround arrangement
[68], or be replaced with concentric rings [69]. However, in-
creasing the number of electrodes generally allows greater
specificity and multifocal targeting [70, 71]. These techniques
are yet to be applied for the treatment of PD.
Transcranial Alternating Current Stimulation
To date, the application of tACS on PD symptomology has
remained experimental. Indeed, while the literature on tACS
has expanded greatly over the past 15 years (since the reintro-
duction of the technique [11]), there have been only a handful
of papers that have applied tACS in PD patients.
Krause et al. has so far presented the only application of
beta-frequency stimulation in a PD cohort [72]. In their sham-
controlled, double-blinded study, the authors assessed the im-
pact of 20 Hz tACS on cortico-muscular coupling and motor
performance in PDwhile patients wereONmedication, versus
a control group. Their aim was not to alleviate symptoms, but
rather to assess the impact on isometric contraction and the
regularity of finger tapping—since beta-frequencies are asso-
ciated with bradykinesias in PD [19], and 20 Hz tACS has
previously been shown to slow movement in healthy individ-
uals [73, 74]. Stimulation attenuated beta-band cortico-mus-
cular coupling during isometric contraction, and reduced am-
plitude variability during finger tapping in the PD group, but
had no discernible impact on the control group. They con-
clude that PD may in fact be more responsive to tACS due
to the altered pathophysiological brain state.
Taking a different approach, Shill et al. [75] applied high-
frequency (77.5 Hz), high-amplitude (15 mA) stimulation as a
prospective, offline treatment, delivering stimulation over
45 min per session for 10 days. They concluded that stimula-
tion bore no significant benefits over placebo in UPDRS (parts
I-III), anxiety, depression or sleepiness scales over the course
of the experiment. Despite this, gamma frequency stimulation
has been shown to speed motor responses in healthy individ-
uals [76], and so could be further trialled as a treatment for
bradykinesia.
Adaptive Stimulation
Due to the lack of experimental data relating to open-loop
stimulation, no on-demand protocols have so far been trialled.
However, closed-loop stimulation has been attempted
focussing on the symptom of resting tremor. Brittain et al.
[51] demonstrated that tACS could partially entrain and ampli-
tude modulate peripheral tremor as recorded by accelerometery.
In this study, the peripheral movement itself was employed
as a proxy for central brain activity [77], using closed-loop
control to align the stimulation waveform with on-going
movements in real-time. It was demonstrated that sustained
closed-loop stimulation led to an order-of-magnitude in-
crease in the effect-size of suppression of the pathological
tremor over the open-loop configuration, without
impacting gross motor performance. This study demon-
strates the importance of temporally guided stimulation
paradigms [78], especially in modalities where the strength
of stimulation is weak compared to endogenous/aberrant
brain activity (i.e. see [12, 79]).
The influence of tACS over the cerebellum has also been
assessed in relation to PD tremor. In a cohort of mixed PD and
ET patients, tACS applied between ipsilateral cerebellum and
extracephalic contralateral shoulder was shown to entrain
those tremors that were pliant to oscillate within a limited
range of frequencies [46]. In the same study, it was shown that
PD tremor displayed this pliancy to a greater extent than pa-
tients with ET, suggesting a greater tendency to entrainment.
However, it should be noted that a direct comparison between
PD and ET patients was not significant, possibly due to the
small sample of participants in this study.
Pharmacological Action and Interaction
When discussing tACS, the emphasis is usually on temporal
alignment to maximise the impact of sub-threshold modula-
tions in the membrane potential [78]. However, there is grow-
ing evidence that tACS is also responsible for changes in
neurotransmitter concentrations and cortical plasticity. For in-
stance, stimulation at gamma-frequencies (75 Hz in this case)
has been shown to drive local GABAA inhibition [80]. In
addition, Guerra et al. [81] demonstrated the abolition of cho-
linergic short-latency afferent inhibition (SAI) during tACS at
20 Hz (separate from the phase-dependent effects that were
also observed). Clearly, we must also consider the impact of
alternating currents on neurochemical processes in our exper-
imental designs, even if only to monitor and mitigate the re-
active impact that these changes might cause to our
neuromodulation efforts.
Field Shaping
In both DBS and tCS, complex field shaping is made
possible by developments in hardware. In tACS however,
high-density electrode configurations offer the possibility
to deliver not only more focal forms of stimulation, but
also novel stimulation protocols. For instance, the rein-
forcement or disruption of synchronised neural rhythms
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between brain regions through in- and out-of-phase stim-
ulation [82–85]. One downside has been the induction of
steeper current gradients focussed over a smaller area that
can lead to an exacerbation of sensory side effects (a
particular problem when time-varying currents are
employed). Indeed, perhaps the limiting factor in the de-
livery of tCS so far has been discomfort arising from
cutaneous nociception [86].
Recently, there have been new developments in the
delivery of tCS that may overcome some of these unwant-
ed sensory side effects and, in so doing, permit the deliv-
ery of higher-intensity stimulation. The first is the sug-
gested use of topical anaesthetics to numb sensation (as
described in [86]). The second is the use of high-
frequency amplitude-modulated stimulation, which de-
livers current beyond the response range of cutaneous
receptors. This approach offers the additional benefit of
reducing (or removing) stimulation artefact from the fre-
quency range of interest, permitting simultaneous MEG or
even EEG recordings to be made. The approach has been
trialled with some success [87], although the knock-on
impact of amplitude-modulated tACS is that the neural
response to such beat frequencies is unclear; indeed, it
may be that substantially stronger currents are required
to induce neural modulation after signal loss due to the
presumed (partial) demodulation of the stimulus wave-
form at the neuronal level. This is compounded by our
lack of understanding about the mechanism through
which demodulation occurs [88], although it possibly re-
flects nonlinearities in the cell membrane response [78,
87]. In support of this, triangular stimulation waveforms
have been reported to modulate brain activity perhaps
more effectively than sine-waves [89]. One further devel-
opment is the advent of temporal interference stimulation,
which applies two separate high-frequency (kHz range)
stimulation waveforms simultaneously. At their intersec-
tion, an amplitude-modulated waveform is produced
[90••]. This elegant solution permits considerable flexibil-
ity in field steering, and raises the exciting prospect of
selectively targeting deeper brain regions. Although the
technique has only been demonstrated in mice at this
point, translation into human studies appears immediately
feasible, although it remains to be seen whether such
forms of stimulation can induce sufficient modulation in
a reliable, controlled manner to offer real therapeutic pros-
pects. One drawback of high-density arrangements is that
as the focality of stimulation improves, the need for accurate
placement of electrodes, and incorporation of individualised head
models to provide reliable current steering becomes a necessity,
significantly complicating the approach. Nevertheless, such ad-
vancements provide the opportunity to develop these techniques
as either offline therapies, pre-surgical screening tools, or even as
a precursor to a fully implanted epidural stimulation system.
Direct Cortical Stimulation
Direct stimulation of the motor cortex in the treatment of
PD has been trialled with varying success over the years
[91]. Stimulation can be subdural, but minimally invasive
epidural methods seem to be preferred due to reduced
surgical risks [91]. Efficacy has been variable, but is gen-
erally considered less efficacious than DBS [92]. This is
potentially due to the dependency between stimulation
site (cortical or sub-cortical) and behavioural effects, and
confounded by limits on stimulation intensity in order to
prevent seizure onset. Stimulation efficacy could be im-
proved by determining the optimum stimulation site ac-
cording to patient specific brain connectivity in order to
reveal the “sweet spot” for modulating downstream nuclei
in the motor circuit [93]. This type of approaches could be
important for treating disorders like PD that arise from
complex network interactions. DBS is associated with
greater surgical risks than epidural methods, and is not
effective in all patients, especially those who prove non-
responsive to dopaminergic medication [94]. Indeed, di-
rect cortical stimulation may be a treatment option in pa-
tients who prove unresponsive to, or are otherwise
contraindicative for DBS, demonstrating improvements
in gait and axial symptoms [92]. Meanwhile, non-
invasive forms of stimulation such as tACS has shown
some promise in closed-loop forms of stimulation, but
such closed-loop strategies require chronic applications,
which are not currently realisable in its present form.
Could direct cortical stimulation provide a harmonious so-
lution to some of these problems and offer a hybrid alternative
therapy? Direct cortical stimulation possesses many attributes
that make it a desirable intervention. It can be delivered chron-
ically, is minimally invasive offering reduced surgical risks,
and provides focal stimulation of targeted cortical regions.
Does direct cortical stimulation therefore offer a convenient
minimally invasive surgical option for the implementation of a
chronic form of closed-loop tACS? Techniques such as tem-
poral interference could be adapted to chronic applications
across multiple electrodes [90••], offering deep epidural stim-
ulation and targeting of midline structures. Such stimulus de-
livery could offer advantages over existing direct cortical
stimulation, including the potential for improved efficacy.
Compared to tACS, direct cortical stimulation can deliver
stronger and focussed current densities. Compared with pul-
satile stimulation, sine-wave modulation may reduce seizure
risk due to the less acerbic nature of the stimulus.
Common Goals and Future Directions
There are clear parallels to be drawn for the next-generation of
electrical neuromodulation techniques. There is a
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tendency to seek greater anatomical and functional speci-
ficity. All forms have been associated with neuroplastic
effects and pharmacological dependencies, and an emerg-
ing recognition that underlying brain state is an important
consideration in effective neuromodulation. But these fac-
tors also overlap. Greater anatomical specificity goes
hand-in-hand with the identification and preferential
targeting of biological signatures of pathology, which in
turn drives on-demand and closed-loop strategies. The
pharmacological impact of stimulation, either by direct
or indirect methods, will affect the efficacy of subsequent
periods of stimulation. tDCS presently appears most suit-
able as an adjunct method in priming and rehabilitative
training.
Conclusions
Electrical neuromodulation remains a promising and pow-
erful tool to interrogate neural circuits, with recent devel-
opments favouring greater anatomical and functional
specificity. Techniques such as DBS are well established
and have received a recent resurgence in innovation that
offers new therapeutic options. Meanwhile, tCS remains a
technique in its infancy, where the mechanisms of action
remain unclear. As our understanding of these techniques
improves, our capacity to trial novel therapeutic interven-
tions also improves. While the surveyed approaches have
shown early promise in increasing the potency and selec-
tivity of stimulation, further clinical trials are clearly re-
quired. Continued technological developments offer the
opportunity of new and innovative approaches to probe
PD pathophysiology and abate the symptoms of PD.
Funding Information This research was funded by the Medical Research
Council (MR/N003446/1, MR/M014762/1).
Compliance with Ethical Standards
Conflict of Interest Dr. Brittain has a patent GB1700767.5 (Method and
System For Determining Tremor Status) pending to Oxford University
Innovation Limited.
Dr. Cagnan has nothing to disclose.
Human and Animal Rights and Informed Consent This article does not
contain any studies with human or animal subjects performed by any of
the authors.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. Parkinson J. An essay on the shaking palsy. London: Whittingham
and Rowland Sherwood, Neely and Jones; 1817.
2. Obeso JA, StamelouM, Goetz CG, PoeweW, Lang AE,Weintraub
D, et al. Past, present, and future of Parkinson’s disease: a special
essay on the 200th anniversary of the shaking palsy. Mov Disord.
2017;32(9):1264–310.
3. Pandey S, Srivanitchapoom P. Levodopa-induced dyskinesia: clin-
ical features, pathophysiology, and medical management. Ann
Indian Acad Neurol. 2017;20(3):190–8.
4. Bergman H, Wichmann T, DeLong MR. Reversal of experimental
parkinsonism by lesions of the subthalamic nucleus. Science.
1990;249(4975):1436–8.
5. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao
DM, et al. Acute and long-term effects of subthalamic nucleus
stimulation in Parkinson’s disease. Stereotact Funct Neurosurg.
1994;62(1–4):76–84.
6. Sugiyama K, Nozaki T, Asakawa T, Koizumi S, Saitoh O, Namba
H. The present indication and future of deep brain stimulation.
Neurol Med Chir (Tokyo). 2015 May;55(5):416–21.
7. Narang P, Glowacki A, Lippmann S. Electroconvulsive therapy
intervention for Parkinson’s disease. Innov Clin Neurosci.
2015;12(9–10):25–8.
8 . Cumper SK, Ahle GM, Liebman LS, Ke l lne r CH.
Electroconvulsive therapy (ECT) in Parkinson’s disease: ECS
and dopamine enhancement. J ECT. 2014;30(2):122–4.
9. Weintraub D, Elias WJ. The emerging role of transcranial magnetic
resonance imaging-guided focused ultrasound in functional neuro-
surgery. Mov Disord Off J Mov Disord Soc. 2017;32(1):20–7.
10. Krishna V, Sammartino F, Rezai A. A review of the current thera-
pies, challenges, and future directions of transcranial focused ultra-
sound technology: advances in diagnosis and treatment. JAMA
Neurol 2017
11. Woods AJ, Antal A, Bikson M, Boggio PS, Brunoni AR, Celnik P,
et al. A technical guide to tDCS, and related non-invasive brain
stimulation tools. Clin Neurophysiol. 2016;127(2):1031–48.
12. Ali MM, Sellers KK, Fröhlich F. Transcranial alternating current
stimulation modulates large-scale cortical network activity by net-
work resonance. J Neurosci. 2013;33(27):11262–75.
13. Ponce FA, Lozano AM. Chapter 16 - Deep brain stimulation: state
of the art and novel stimulation targets. In: Björklund A, Cenci MA,
editors. Progress in brain research [Internet]. Elsevier; 2010 [cited
2017 Dec 15]. p. 311–24. (Recent Advances in Parkinson’S
Disease; vol. 184). Available from: http://www.sciencedirect.com/
science/article/pii/S0079612310840166
14. Shukla AW, Okun MS. State of the art for deep brain stimulation
therapy in movement disorders: a clinical and technological per-
spective. IEEE Rev Biomed Eng. 2016;9:219–33.
15. Lozano CS, Tam J, Lozano AM. The changing landscape of
surgery for Parkinson’s disease. Mov Disord Off J Mov Disord
Soc. 2017;30
16. Kurtis MM, Rajah T, Delgado LF, Dafsari HS. The effect of deep
brain stimulation on the non-motor symptoms of Parkinson’s dis-
ease: a critical review of the current evidence. NPJ Park Dis.
2017;3:16024.
17. Hariz M. Deep brain stimulation: new techniques. Parkinsonism
Relat Disord. 2014;20(Suppl 1):S192–6.
Curr Behav Neurosci Rep (2018) 5:170–178 175
18. Grill WM, Snyder AN, Miocinovic S. Deep brain stimulation cre-
ates an informational lesion of the stimulated nucleus. Neuroreport.
2004;15(7):1137–40.
19. Brittain J-S, Brown P. Oscillations and the basal ganglia: motor
control and beyond. NeuroImage. 2014;85(Pt 2):637–47.
20. Eusebio A, Thevathasan W, Gaynor LD, Pogosyan A, Bye E,
Foltynie T, et al. Deep brain stimulation can suppress pathological
synchronisation in parkinsonian patients. J Neurol Neurosurg
Psychiatry. 2011;82(5):569–73.
21. Kühn AA, Kupsch A, Schneider G-H, Brown P. Reduction in sub-
thalamic 8–35 Hz oscillatory activity correlates with clinical im-
provement in Parkinson’s disease. Eur J Neurosci. 2006;23(7):
1956–60.
22. Kühn AA, Tsui A, Aziz T, Ray N, Brücke C, Kupsch A, et al.
Pathological synchronisation in the subthalamic nucleus of patients
with Parkinson’s disease relates to both bradykinesia and rigidity.
Exp Neurol. 2009;215(2):380–7.
23. Ray NJ, Jenkinson N, Wang S, Holland P, Brittain JS, Joint C, et al.
Local field potential beta activity in the subthalamic nucleus of
patients with Parkinson’s disease is associated with improvements
in bradykinesia after dopamine and deep brain stimulation. Exp
Neurol. 2008;213(1):108–13.
24. Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E,
Hodaie M, et al. Beta oscillatory activity in the subthalamic nucleus
and its relation to dopaminergic response in Parkinson’s disease. J
Neurophysiol. 2006;96(6):3248–56.
25. Fytagoridis A, Åström M, Wårdell K, Blomstedt P. Stimulation-
induced side effects in the posterior subthalamic area: distribution,
characteristics and visualization. Clin Neurol Neurosurg.
2013;115(1):65–71.
26. Pollo C, Kaelin-Lang A, Oertel MF, Stieglitz L, Taub E, Fuhr P,
et al. Directional deep brain stimulation: an intraoperative double-
blind pilot study. Brain J Neurol. 2014;137(Pt 7):2015–26.
27. Dembek TA, Reker P, Visser-Vandewalle V, Wirths J, Treuer H,
Klehr M, et al. Directional DBS increases side-effect thresholds-a
prospective, double-blind trial. Mov Disord Off J Mov Disord Soc.
2017;32(10):1380–8.
28. Reker P, Dembek TA, Becker J, Visser-Vandewalle V, Timmermann
L. Directional deep brain stimulation: a case of avoiding dysarthria
with bipolar directional current steering. Parkinsonism Relat Disord.
2016;31:156–8.
29. Steigerwald F, Müller L, Johannes S, Matthies C, Volkmann J.
Directional deep brain stimulation of the subthalamic nucleus: a
pilot study using a novel neurostimulation device. Mov Disord
Off J Mov Disord Soc. 2016;31(8):1240–3.
30. Fernández-García C, Foffani G, Dileone M, Catalán-Alonso MJ,
González-Hidalgo M, Barcía JA, et al. Directional local field po-
tential recordings for symptom-specific optimization of deep brain
stimulation. Mov Disord Off J Mov Disord Soc. 2017;32(4):626–8.
31. Tinkhauser G, Pogosyan A, Debove I, Nowacki A, Shah SA, Seidel
K, et al. Directional local field potentials: a tool to optimize deep
brain stimulation. Mov Disord Off J Mov Disord Soc. 2017 18;
32. Timmermann L, Jain R, Chen L, Maarouf M, Barbe MT, Allert N,
et al. Multiple-source current steering in subthalamic nucleus deep
brain stimulation for Parkinson’s disease (the VANTAGE study): a
non-randomised, prospective, multicentre, open-label study. Lancet
Neurol. 2015;14(7):693–701.
33. Bour LJ, Lourens MAJ, Verhagen R, de Bie RMA, van den
Munckhof P, Schuurman PR, et al. Directional recording of subtha-
lamic spectral power densities in Parkinson’s disease and the effect of
steering deep brain stimulation. Brain Stimulat. 2015;8(4):730–41.
34. Brittain J-S, Sharott A, Brown P. The highs and lows of beta activity
in cortico-basal ganglia loops. Eur J Neurosci. 2014;39(11):1951–9.
35. Eusebio A, Cagnan H, Brown P. Does suppression of oscillatory
synchronisation mediate some of the therapeutic effects of DBS in
patients with Parkinson’s disease? Front Integr Neurosci [Internet].
2012 [cited 2018 Feb 15];6. Available from: https://doi.org/10.
3389/fnint.2012.00047/full
36. Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, Shapiro H,
et al. Subthalamic deep brain stimulation and impulse control in
Parkinson’s disease. Eur J Neurol. 2009;16(4):493–7.
37. Guehl D, Cuny E, Benazzouz A, Rougier A, Tison F, Machado
S, et al. Side-effects of subthalamic stimulation in Parkinson’s
disease: clinical evolution and predictive factors. Eur J Neurol.
2006;13(9):963–71.
38. Little S, Tripoliti E, Beudel M, Pogosyan A, Cagnan H, Herz D,
et al. Adaptive deep brain stimulation for Parkinson’s disease dem-
onstrates reduced speech side effects compared to conventional
stimulation in the acute setting. J Neurol Neurosurg Psychiatry.
2016;87(12):1388–9.
39.•• Cagnan H, Pedrosa D, Little S, Pogosyan A, Cheeran B, Aziz T,
et al. Stimulating at the right time: phase-specific deep brain stim-
ulation. Brain J Neurol. 2017;140(1):132–45. First demonstration
in humans of the effectiveness of phase-specific closed-loop stim-
ulation during DBS.
40. Baizabal-Carvallo JF, Alonso-Juarez M. Low-frequency deep brain
stimulation for movement disorders. Parkinsonism Relat Disord.
2016;31(Supplement C):14–22.
41. Eusebio A, Chen CC, Lu CS, Lee ST, Tsai CH, Limousin P,
et al. Effects of low-frequency stimulation of the subthalamic
nucleus on movement in Parkinson’s disease. Exp Neurol.
2008;209(1):125–30.
42. Kelley R, Flouty O, Emmons EB, Kim Y, Kingyon J, Wessel JR,
et al. A human prefrontal-subthalamic circuit for cognitive control.
Brain [Internet]. [cited 2017 Dec 14]; Available from: https://doi.
org/10.1093/brain/awx300/4665976
43. CagnanH, Little S, Foltynie T, Limousin P, Zrinzo L, HarizM, et al.
The nature of tremor circuits in parkinsonian and essential tremor.
Brain J Neurol. 2014;137(Pt 12):3223–34.
44. Cagnan H, Brittain J-S, Little S, Foltynie T, Limousin P, Zrinzo L,
et al. Phase dependent modulation of tremor amplitude in essential
tremor through thalamic stimulation. Brain J Neurol. 2013;136(Pt
10):3062–75.
45. Swan BD, Brocker DT, Hilliard JD, Tatter SB, Gross RE, Turner DA,
et al. Short pauses in thalamic deep brain stimulation promote tremor
and neuronal bursting. Clin Neurophysiol. 2016;127(2):1551–9.
46. Brittain J-S, Cagnan H, Mehta AR, Saifee TA, Edwards MJ, Brown
P. Distinguishing the central drive to tremor in Parkinson’s disease
and essential tremor. J Neurosci. 2015;35(2):795–806.
47. di Biase L, Brittain J-S, Shah SA, Pedrosa DJ, Cagnan H,Mathy A,
et al. Tremor stability index: a new tool for differential diagnosis in
tremor syndromes. Brain J Neurol. 2017;140(7):1977–86.
48. Duval C, Daneault J-F, Hutchison WD, Sadikot AF. A brain net-
work model explaining tremor in Parkinson’s disease. Neurobiol
Dis. 2016;85(Supplement C):49–59.
49. Dirkx MF,den Ouden HE, Aarts E, Timmer MHM, Bloem BR,
et al. Dopamine controls Parkinson’s tremor by inhibiting the cere-
bellar thalamus. Brain 2017;140(3):721–734.
50. Algarni M, Fasano A. The overlap between essential tremor
and Parkinson disease . Parkinsonism Relat Disord.
2018;46(Suppl 1):S101–4.
51. Brittain J-S, Probert-Smith P, Aziz TZ, Brown P. Tremor suppres-
sion by rhythmic transcranial current stimulation. Curr Biol CB.
2013;23(5):436–40.
52. Priori A, Berardelli A, Rona S, Accornero N, Manfredi M.
Polarization of the human motor cortex through the scalp.
Neuroreport. 1998;9(10):2257–60.
53. Nitsche MA, Paulus W. Excitability changes induced in the human
motor cortex by weak transcranial direct current stimulation. J
Physiol. 2000;527(3):633–9.
54. Lefaucheur J-P, Antal A, Ayache SS, Benninger DH, Brunelin J,
Cogiamanian F, et al. Evidence-based guidelines on the therapeutic
176 Curr Behav Neurosci Rep (2018) 5:170–178
use of transcranial direct current stimulation (tDCS). Clin
Neurophysiol Off J Int Fed Clin Neurophysiol. 2017;128(1):56–92.
55. Benninger DH, Hallett M. Non-invasive brain stimulation for
Parkinson’s disease: current concepts and outlook 2015.
NeuroRehabilitation. 2015;37(1):11–24.
56. Winkler C, Reis J, Hoffmann N, Gellner A-K, Münkel C, Curado
MR, et al. Anodal transcranial direct current stimulation enhances
survival and integration of dopaminergic cell transplants in a rat
Parkinson model. eNeuro. 2017;4(5):ENEURO.0063–17.2017.
57. Stagg CJ, Nitsche MA. Physiological basis of transcranial direct
current stimulation. Neurosci Rev J Bringing Neurobiol Neurol
Psychiatry. 2011;17(1):37–53.
58.• McLaren ME, Nissim NR, Woods AJ. The effects of medication
use in transcranial direct current stimulation: a brief review. Brain
Stimulat. 2017. Provides an important contemporary review of
evidence concerning the effects of pharmacology on tDCS-
induced excitability.
59. Li LM, Uehara K, Hanakawa T. The contribution of interindividual
factors to variability of response in transcranial direct current stim-
ulation studies. Front Cell Neurosci. 2015;9:181.
60. Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F,
et al. Dopaminergic modulation of long-lasting direct current-
induced cortical excitability changes in the human motor cortex.
Eur J Neurosci. 2006;23(6):1651–7.
61. Monte-Silva K, Liebetanz D, Grundey J, Paulus W, Nitsche MA.
Dosage-dependent non-linear effect of l-dopa on human motor cor-
tex plasticity. J Physiol. 2010;588(18):3415–24.
62. Fresnoza S, Stiksrud E, Klinker F, Liebetanz D, Paulus W, Kuo
M-F, et al. Dosage-dependent effect of dopamine D2 receptor
activation on motor cortex plasticity in humans. J Neurosci.
2014;34(32):10701–9.
63. Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K,
Frommann K, et al. GABAergic modulation of DC stimulation-
induced motor cortex excitability shifts in humans. Eur J
Neurosci. 2004;19(10):2720–6.
64. Kim S, Stephenson MC, Morris PG, Jackson SR. tDCS-induced
alterations in GABA concentration within primary motor cortex
predict motor learning and motor memory: a 7 T magnetic reso-
nance spectroscopy study. NeuroImage. 2014;99(100):237–43.
65. Kabakov AY, Muller PA, Pascual-Leone A, Jensen FE, Rotenberg
A. Contribution of axonal orientation to pathway-dependent mod-
ulation of excitatory transmission by direct current stimulation in
isolated rat hippocampus. J Neurophysiol. 2012;107(7):1881–9.
66. Radman T, Ramos RL, Brumberg JC, Bikson M. Role of cortical
cell type and morphology in subthreshold and suprathreshold uni-
form electric field stimulation in vitro. Brain Stimulat. 2009;2(4):
215–28. 228.e1–3
67. Rahman A, Reato D, Arlotti M, Gasca F, Datta A, Parra LC, et al.
Cellular effects of acute direct current stimulation: somatic and
synaptic terminal effects. J Physiol. 2013;591(10):2563–78.
68. Datta A, Bansal V, Diaz J, Patel J, Reato D, BiksonM. Gyri-precise
head model of transcranial DC stimulation: improved spatial
focality using a ring electrode versus conventional rectangular
pad. Brain Stimulat. 2009;2(4):201–7.
69. Gbadeyan O, Steinhauser M, McMahon K, Meinzer M. Safety,
tolerability, blinding efficacy and behavioural effects of a novel
MRI-compatible, high-definition tDCS set-up. Brain Stimul Basic
Transl Clin Res Neuromodulation. 2016;9(4):545–52.
70. Dannhauer M, Brooks D, Tucker D,MacLeod R. A Pipeline for the
simulation of transcranial direct current stimulation for realistic hu-
man head models using SCIRun/BioMesh3D. In: 2012 Annual
International Conference of the IEEE Engineering in Medicine
and Biology Society 2012. p. 5486–9.
71. Ruffini G, Fox MD, Ripolles O, Miranda PC, Pascual-Leone A.
Optimization of multifocal transcranial current stimulation for
weighted cortical pattern targeting from realistic modeling of elec-
tric fields. NeuroImage. 2014;89(Supplement C):216–25.
72. Krause V, Wach C, Südmeyer M, Ferrea S, Schnitzler A,
Pollok B. Cortico-muscular coupling and motor performance
are modulated by 20 Hz transcranial alternating current stim-
ulation (tACS) in Parkinson’s disease. Front Hum Neurosci.
2013;7:928.
73. Joundi RA, Jenkinson N, Brittain J-S, Aziz TZ, Brown P. Driving
oscillatory activity in the human cortex enhances motor perfor-
mance. Curr Biol CB. 2012;22(5):403–7.
74. Pogosyan A, Gaynor LD, Eusebio A, Brown P. Boosting cortical
activity at beta-band frequencies slows movement in humans. Curr
Biol CB. 2009;19(19):1637–41.
75. Shill HA, Obradov S, Katsnelson Y, Pizinger R. A randomized,
double-blind trial of transcranial electrostimulation in early
Parkinson’s disease. Mov Disord Off J Mov Disord Soc.
2011;26(8):1477–80.
76. Joundi RA, Brittain J-S, Green AL, Aziz TZ, Brown P,
Jenkinson N. Persistent suppression of subthalamic beta-band
activity during rhythmic finger tapping in Parkinson’s disease.
Clin Neurophysiol Off J Int Fed Clin Neurophysiol .
2013;124(3):565–73.
77. Timmermann L, Gross J, Dirks M, Volkmann J, Freund H-J,
Schnitzler A. The cerebral oscillatory network of parkinsonian rest-
ing tremor. Brain. 2003;126(1):199–212.
78. Thut G, Bergmann TO, Fröhlich F, Soekadar SR, Brittain J-S,
Valero-Cabré A, et al. Guiding transcranial brain stimulation by
EEG/MEG to interact with ongoing brain activity and associated
functions: a position paper. Clin Neurophysiol Off J Int Fed Clin
Neurophysiol. 2017;128(5):843–57.
79. Fröhlich F, McCormick DA. Endogenous electric fields may guide
neocortical network activity. Neuron. 2010;67(1):129–43.
80. Nowak M, Hinson E, van Ede F, Pogosyan A, Guerra A, Quinn A,
et al. Driving human motor cortical oscillations leads to behavior-
ally relevant changes in local GABAA inhibition: a tACS-TMS
study. J Neurosci. 2017;37(17):4481–92.
81. Guerra A, Pogosyan A, Nowak M, Tan H, Ferreri F, Di Lazzaro V,
et al. Phase dependency of the human primary motor cortex and
cholinergic inhibition cancelation during beta tACS. Cereb Cortex
N Y NY. 2016;26(10):3977–90.
82. Helfrich RF, Knepper H, Nolte G, Strüber D, Rach S, Herrmann
CS, et al. Selective modulation of interhemispheric functional con-
nectivity by HD-tACS shapes perception. PLoS Biol. 2014;12(12):
e1002031.
83. Strüber D, Rach S, Trautmann-Lengsfeld SA, Engel AK, Herrmann
CS. Antiphasic 40Hz oscillatory current stimulation affects bistable
motion perception. Brain Topogr. 2014;27(1):158–71.
84. Saturnino GB, Madsen KH, Siebner HR, Thielscher A. How to
target inter-regional phase synchronization with dual-site transcra-
nial alternating current stimulation. NeuroImage. 2017;163:68–80.
85. Bächinger M, Zerbi V, MoisaM, Polania R, Liu Q, Mantini D, et al.
Concurrent tACS-fMRI reveals causal influence of power synchro-
nized neural activity on resting state fMRI connectivity. J Neurosci.
2017;37(18):4766–77.
86. Khatoun A, Asamoah B, Laughlin MM. Simultaneously excitatory
and inhibitory effects of transcranial alternating current stimulation
revealed using selective pulse-train stimulation in the rat motor
cortex. J Neurosci. 2017:1390–17.
87. Witkowski M, Garcia-Cossio E, Chander BS, Braun C, Birbaumer
N, Robinson SE, et al. Mapping entrained brain oscillations during
transcranial alternating current stimulation (tACS). NeuroImage.
2016;140:89–98.
88. Dmochowski J, Bikson M. Noninvasive neuromodulation goes
deep. Cell. 2017;169(6):977–8.
89. Dowsett J, Herrmann CS. Transcranial alternating current stimula-
tion with sawtooth waves: simultaneous stimulation and EEG
Curr Behav Neurosci Rep (2018) 5:170–178 177
recording. Front HumNeurosci [Internet]. 2016Mar 29 [cited 2017
Dec 14];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4809871/
90.•• Grossman N, Bono D, Dedic N, Kodandaramaiah SB, Rudenko
A, Suk H-J, et al. Noninvasive deep brain stimulation via tem-
porally interfering electric fields. Cell. 2017;169(6):1029–
1041.e16. Introduced the temporal interference technique
which enables non-invasive delivery of alternating current stim-
ulation to deep regions of the brain.
91. LavanoA,Guzzi G, DERoseM, RomanoM,Della Torre A, Vescio
G, et al. Minimally invasive motor cortex stimulation for
Parkinson’s disease. J Neurosurg Sci. 2017;61(1):77–87.
92. De Rose M, Guzzi G, Bosco D, Romano M, Lavano SM, Plastino
M, et al. Motor cortex stimulation in Parkinson’s disease [Internet].
Neurology Research International. 2012 [cited 2017 Dec 15].
Available from: https://www.hindawi.com/journals/nri/2012/
502096/
93. Horn A, Neumann W-J, Degen K, Schneider G-H, Kühn AA.
Toward an electrophysiological ‘sweet spot’ for deep brain stimu-
lation in the subthalamic nucleus. Hum Brain Mapp 2017
94. Suarez-Cedeno G, Suescun J, SchiessMC. Earlier intervention with
deep brain stimulation for Parkinson’s disease. Park Dis.
2017;2017:9358153.
178 Curr Behav Neurosci Rep (2018) 5:170–178
